ATAI Life Sciences NV (NAS:ATAI)
$ 1.61 -0.02 (-1.23%) Market Cap: 269.52 Mil Enterprise Value: 187.43 Mil PE Ratio: 0 PB Ratio: 1.22 GF Score: 27/100

ATAI Life Sciences NV at Citi Winter Biotech Virtual Bus Tour Transcript

Mar 22, 2022 / 03:00PM GMT
Release Date Price: $5.55 (+5.11%)
Neena Marie Bitritto;Garg
Citigroup Inc., Research Division - VP & Analyst

Well, good morning, everyone, and thank you so much for taking the time to join Citi's 2022 Virtual Bus Tour. I am very pleased to be joined by the management team from atai Life Sciences for our next session. So we have the company's CEO, Florian Brand; and the company's Chief Scientific Officer, Srinivas Rao.

And I just wanted to remind everybody, since this is a virtual bus tour, you are free to raise your hand and ask questions. We do want this to be interactive. (Operator Instructions) And so before we jump to the questions, I did want to turn it over to Florian and Srini, if you guys want to make any opening remarks.

Florian Brand;Srinivas G. Rao
Atai Life Sciences N.V. - Co-Founder, MD & CEO;Atai Life Sciences N.V. - Co-Founder

Sure. And I'm not sure if everyone knows us. I see some familiar names here. But like Srini, why don't you do a quick introduction on yourself and then I do a very short one on myself?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot